Real‐life benefits of intrajejunal levodopa infusion therapy in four patients with the parkinsonian variant of progressive supranuclear palsy: A 1‐year follow‐up data report

Background Progressive supranuclear palsy (PSP) is a progressive neurodegenerative condition presenting with different clinical endophenotypes. The parkinsonian variant of PSP (PSP‐P) is characterised by early but fading responsiveness to high‐dose levodopa therapy; however, high‐dose oral therapy i...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Brain and behavior Ročník 12; číslo 9; s. e2547 - n/a
Hlavní autoři:	Metta, Vinod, Chaudhuri, K. Ray, Leta, Valentina, Mridula, Kandadai Rukmini, Koduri, Chaitanya, Deepak, Sai, Kalpala, Rakesh, Reddy, Nageswar, Chung‐Faye, Guy, Borgohain, Rupam
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States John Wiley & Sons, Inc 01.09.2022 John Wiley and Sons Inc Wiley
Témata:	Antiparkinson Agents - therapeutic use Cosmetics Dementia Diabetes Dopamine Drug dosages Family medical history Follow-Up Studies Gait Hallucinations Hospitals Humans Hypertension intrajejunal levodopa‐carbidopa infusion Levodopa - adverse effects motor and nonmotor symptoms Original Parkinson Disease Parkinson's disease Parkinsonian variant of progressive supranuclear palsy Patients Quality of Life Sleep Supranuclear Palsy, Progressive India intrajejunal levodopa-carbidopa infusion Parkinsonian variant of progressive supranuclear palsy motor and nonmotor symptoms quality of life
ISSN:	2162-3279, 2162-3279
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!